Understanding cervical cancer prevention in American Indian and Alaska Native women
Utilization of cervical cancer prevention tools and role of high-risk HPV type in the persistent cervical cancer disparities experienced by American Indian/Alaska Native women
This study looks at why American Indian and Alaska Native women may face higher rates of cervical cancer and how things like HPV vaccinations and pap smears can help, with the goal of finding ways to make these important health services more accessible and effective for them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10894269 on NIH RePORTER |
What this research studies
This research investigates the factors contributing to cervical cancer disparities among American Indian and Alaska Native women, focusing on the use of prevention tools like HPV vaccination and pap smear screenings. The study aims to evaluate how these tools are utilized within this population and the impact of high-risk HPV types on cervical cancer incidence. By analyzing vaccination rates and screening practices, the research seeks to identify barriers and improve access to these critical health services. The ultimate goal is to reduce the incidence and mortality rates of cervical cancer in these communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are American Indian and Alaska Native women who are at risk for cervical cancer.
Not a fit: Patients who do not identify as American Indian or Alaska Native may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cervical cancer prevention strategies and reduced health disparities for American Indian and Alaska Native women.
How similar studies have performed: Previous research has shown success in improving cervical cancer outcomes through targeted prevention strategies in underserved populations.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Bruegl, Amanda S — Oregon Health & Science University
- Study coordinator: Bruegl, Amanda S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.